Tokyo Tape
Sign in
← Meiji Holdings

Quarterly report · Q2

2269.TEDINET S100PI81
Period2022-04-01 → 2022-09-30
Filed2022-11-09
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥517.5bn2022-04-01 → 2022-09-30Cons.Net sales
Revenue¥1.01T2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥500.7bn2021-04-01 → 2021-09-30Cons.Net sales
Operating income¥43.2bn2022-04-01 → 2022-09-30Cons.Operating income
Operating income¥50.3bn2021-04-01 → 2021-09-30Cons.Operating income
Ordinary income¥43.9bn2022-04-01 → 2022-09-30Cons.Ordinary income
Ordinary income¥94.0bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥51.8bn2021-04-01 → 2021-09-30Cons.Ordinary income
Profit before tax¥48.3bn2022-04-01 → 2022-09-30Cons.Income before income taxes
Profit before tax¥55.2bn2021-04-01 → 2021-09-30Cons.Income before income taxes
Net income (owners)¥33.4bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥87.5bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥36.6bn2021-04-01 → 2021-09-30Cons.Profit loss attributable to owners of parent
Net income¥34.9bn2022-04-01 → 2022-09-30Cons.Profit loss
Net income¥40.0bn2021-04-01 → 2021-09-30Cons.Profit loss
Total assets¥1.18Tat 2022-09-30Cons.Assets
Total assets¥1.12Tat 2022-03-31Cons.Assets
Total assets¥1.14Tat 2021-09-30Cons.Total assets (5-year summary)
Total liabilities¥426.8bnat 2022-09-30Cons.Liabilities
Total liabilities¥404.4bnat 2022-03-31Cons.Liabilities
Net assets / equity¥757.0bnat 2022-09-30Cons.Net assets
Net assets / equity¥713.0bnat 2022-03-31Cons.Net assets
Net assets / equity¥695.7bnat 2021-09-30Cons.Net assets (5-year summary)
Cash and deposits¥92.1bnat 2022-09-30Cons.Cash and deposits
Cash and deposits¥67.4bnat 2022-03-31Cons.Cash and deposits
Cash & equivalents¥88.7bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥64.9bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥80.9bnat 2021-09-30Cons.Cash and cash equivalents
Cash & equivalents¥39.0bnat 2021-03-31dCons.Cash and cash equivalents
Operating cash flow¥25.2bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥127.5bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥61.2bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥26.0bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥27.6bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥35.6bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in investment activities
Financing cash flow¥20.3bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥77.0bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥14.6bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥237.042022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥123.312022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥607.242021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥252.542021-04-01 → 2021-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥166.442021-07-01 → 2021-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio60.6%at 2022-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio60.3%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio57.4%at 2021-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-09-30−¥292m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-09-30−¥292m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥786m
jpcrp040300-q2r_E21902-000Foodreportable segmentrevenue2022-04-01 → 2022-09-30¥420.6bn
jpcrp040300-q2r_E21902-000Foodreportable segmentrevenue external2022-04-01 → 2022-09-30¥420.4bn
jpcrp040300-q2r_E21902-000Foodreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥278m
jpcrp040300-q2r_E21902-000Foodreportable segmentsegment profit2022-04-01 → 2022-09-30¥29.3bn
jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segmentrevenue2022-04-01 → 2022-09-30¥97.2bn
jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segmentrevenue external2022-04-01 → 2022-09-30¥97.2bn
jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥13m
jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segmentsegment profit2022-04-01 → 2022-09-30¥14.6bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥517.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥517.5bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-09-30¥292m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥44.0bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-09-30−¥468m
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-09-30−¥468m
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-09-30−¥534m
jpcrp040300-q2r_E21902-000Foodreportable segmentrevenue2021-04-01 → 2021-09-30¥409.1bn
jpcrp040300-q2r_E21902-000Foodreportable segmentrevenue external2021-04-01 → 2021-09-30¥408.8bn
jpcrp040300-q2r_E21902-000Foodreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥254m
jpcrp040300-q2r_E21902-000Foodreportable segmentsegment profit2021-04-01 → 2021-09-30¥39.6bn
jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segmentrevenue2021-04-01 → 2021-09-30¥92.1bn
jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segmentrevenue external2021-04-01 → 2021-09-30¥91.9bn
jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥214m
jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segmentsegment profit2021-04-01 → 2021-09-30¥11.3bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-09-30¥501.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-09-30¥500.7bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-09-30¥468m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-09-30¥50.9bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 561
ItemContextValueUnit
Capital stockPrior1YearInstant30000000000JPY
Capital stockCurrentQuarterInstant30000000000JPY
Capital surplusPrior1YearInstant80503000000JPY
Capital surplusCurrentQuarterInstant80620000000JPY
Retained earningsPrior1YearInstant560238000000JPY
Retained earningsCurrentQuarterInstant580951000000JPY
Treasury stockPrior1YearInstant-37868000000JPY
Treasury stockCurrentQuarterInstant-37497000000JPY
Shareholders equityPrior1YearInstant632873000000JPY
Shareholders equityCurrentQuarterInstant654073000000JPY
Valuation difference on available for sale securitiesPrior1YearInstant36347000000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant35131000000JPY
Deferred gains or losses on hedgesPrior1YearInstant73000000JPY
Deferred gains or losses on hedgesCurrentQuarterInstant67000000JPY
Foreign currency translation adjustmentPrior1YearInstant7673000000JPY
Foreign currency translation adjustmentCurrentQuarterInstant30020000000JPY
Remeasurements of defined benefit plansPrior1YearInstant-3631000000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant-2438000000JPY
Valuation and translation adjustmentsPrior1YearInstant40462000000JPY
Valuation and translation adjustmentsCurrentQuarterInstant62781000000JPY
Non controlling interestsPrior1YearInstant39684000000JPY
Non controlling interestsCurrentQuarterInstant40191000000JPY
Net assetsPrior1YearInstant713021000000JPY
Net assetsCurrentQuarterInstant757046000000JPY
Liabilities and net assetsPrior1YearInstant1117459000000JPY
Liabilities and net assetsCurrentQuarterInstant1183879000000JPY
Net salesPrior1YTDDuration500712000000JPY
Net salesCurrentYTDDuration517520000000JPY
Cost of salesPrior1YTDDuration336378000000JPY
Cost of salesCurrentYTDDuration362045000000JPY
Gross profitPrior1YTDDuration164334000000JPY
Gross profitCurrentYTDDuration155474000000JPY
Selling general and administrative expensesPrior1YTDDuration114004000000JPY
Selling general and administrative expensesCurrentYTDDuration112281000000JPY
Operating incomePrior1YTDDuration50330000000JPY
Operating incomeCurrentYTDDuration43193000000JPY
Interest income noiPrior1YTDDuration122000000JPY
Interest income noiCurrentYTDDuration164000000JPY
Dividends income noiPrior1YTDDuration720000000JPY
Dividends income noiCurrentYTDDuration787000000JPY
Equity in earnings of affiliates noiPrior1YTDDuration1699000000JPY
Equity in earnings of affiliates noiCurrentYTDDuration628000000JPY
Foreign exchange gains noiPrior1YTDDuration152000000JPY
Foreign exchange gains noiCurrentYTDDuration－JPY
Other noiPrior1YTDDuration832000000JPY
Other noiCurrentYTDDuration785000000JPY
Non operating incomePrior1YTDDuration3527000000JPY
Non operating incomeCurrentYTDDuration2366000000JPY
Interest expenses noePrior1YTDDuration254000000JPY
Interest expenses noeCurrentYTDDuration241000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass